What does Petlife Pharmaceuticals, Inc. do?

Petlife Pharmaceuticals, Inc. (PTLF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is PTLF's market cap?

Petlife Pharmaceuticals, Inc. (PTLF) has a market capitalization of approximately $19,675, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does PTLF pay a dividend?

No — Petlife Pharmaceuticals, Inc. (PTLF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

PTLF

Petlife Pharmaceuticals, Inc.

OTC·Drug Manufacturers, Specialty & Generic · Healthcare

$0.00$0.00+0.00%

Market cap$19.68K·Market closed·Aug 27 8:00 PM UTC

Price Chart

$0.00+$0.00 (+0.00%)today

+33.33%CAGR +5.93%

Select date range

FromTo

May 14, 2008Aug 29, 2021 → Aug 28, 2026· 5.0 yrsAug 28, 2026

Key Metrics

PTLF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateJul 23

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

Revenue$0.00

Net Income−$3.71M

Net Margin—

Operating Cash Flow−$261.91K

Capital Expenditures$0.00

Free Cash Flow−$261.91K

Return on Equity—

Return on Invested Capital15.6%

Net Debt$793.80K

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for PTLF and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how PTLF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PTLF and 80,000+ other tickers.

About Petlife Pharmaceuticals, Inc.

Based in Los Angeles, California, Petlife Pharmaceuticals, Inc. is dedicated to the discovery, formulation, commercialization, and ongoing support of both medicinal drugs and nutritional supplements for pets. Their primary focus is on addressing canine and feline cancer and various autoimmune conditions, such as arthritis, within the United States market. The company's leading product is Vitalzul, which functions by obstructing the formation of new blood vessels crucial for the growth of solid tumors. Petlife is also progressing the development of Vitalzul into a potent, prescription-only…

CEO: Sebastian Serrell-Watts
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: OTC
Employees: 1
Website: www.petlifepharma.com

Peers

Cannabis Strategic Ventures

Latest News

News Tab

No recent news available.

Frequently Asked Questions About PTLF

What does Petlife Pharmaceuticals, Inc. do?: Petlife Pharmaceuticals, Inc. (PTLF) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is PTLF's market cap?: Petlife Pharmaceuticals, Inc. (PTLF) has a market capitalization of approximately $19,675, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does PTLF pay a dividend?: No — Petlife Pharmaceuticals, Inc. (PTLF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.